SiBionics is a MedTech startup specialized in the R&D and commercialization of active implantable medical devices and medical artificial intelligence. Our company is headquartered in Shenzhen with an additional R&D center and offices located in Los Angeles, Beijing, and Guangzhou. Our project pipeline includes Retinal Prosthesis, Continuous Glucose Monitoring, Diabetic Retinopathy Screening, and Gastric Cancer Screening.

Through sustained innovation of medical technology and comprehensive integration of expertise across a variety of fields, SiBionics is committed to providing innovative medical products and services that are accessible and of the highest caliber for the benefit of public health. Not only do we focus on the demand for health management and chronic conditions management for the broadest swath of the population, but SiBionics also pays special attention to the diagnosis and treatment of rare diseases. Elevated thinking and grounded practice are what we value the most at SiBionics. Only by marrying knowledge with action, can we grow as organizations and individuals and create unique societal values.